In ovarian cancer, germline mutation of SHPRH is associated with a moderate-to-high risk of developing ovarian cancer [91], while in colon cancer, SHPRH has been shown to inhibit Wnt signaling [92]. The gene discussed is SHPRH; the disease is ovarian carcinoma.